Search

Baxter International Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

26.72 -1.44

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

26.58

Max

27.09

Pagrindiniai rodikliai

By Trading Economics

Pajamos

141M

126M

Pardavimai

259M

3B

Pelnas, tenkantis vienai akcijai

0.56

Dividendų pajamingumas

0.73

Pelno marža

4.257

Darbuotojai

37,500

EBITDA

177M

474M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

-3.11% downside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.73%

2.22%

Kitas uždarbis

2026-10-29

Kitas dividendų mokėjimo data

2026-10-01

Kita Ex Dividend data

2026-08-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.3B

14B

Ankstesnė atidarymo kaina

28.16

Ankstesnė uždarymo kaina

26.72

Naujienos nuotaikos

By Acuity

29%

71%

104 / 340 reitingas Healthcare

Baxter International Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-13 19:46; UTC

News

Baxter International recalls Duo-Vent Solution Set lots due to air bubble risks. Shares are trading higher since Wednesday's close despite the recall announcement.

2026-08-12 23:46; UTC

Baxter International Inc shares are higher in after-market trading, supported by recent inflation data that may influence Federal Reserve interest rate decisions.

2026-08-11 23:06; UTC

Baxter International Inc. shares traded roughly flat in after-market hours, reflecting a minor decline from earlier highs amid strong gains over the past month.

2026-08-10 23:16; UTC

Baxter International Inc shares are lower in after-market trading. No specific news was identified to explain this movement amid rising U.S. Treasury yields.

2026-08-07 23:51; UTC

Baxter International Inc shares are lower in after-market hours, retracing from earlier gains amid broader market sentiment influenced by a declining unemployment rate.

2026-08-06 19:36; UTC

Baxter International Inc. shares are lower today, with no specific news identified to explain the movement. The stock remains near its one-month range.

2026-08-05 20:01; UTC

Baxter International Inc shares are lower today, continuing a downward trend. The stock remains above its 20-day moving average despite recent declines.

2026-08-04 22:51; UTC

News

Baxter International shares are lower in after-market hours following the announcement of Interim CFO Anita Zielinski's resignation, effective September 15, 2026.

2026-08-03 23:02; UTC

Baxter International Inc shares are trading lower in after-market hours. Broader market volatility contributed to this decline without any specific company news.

2026-07-31 23:46; UTC

Baxter International shares are lower in after-market trading, following a brief session rise. Rising U.S. Treasury yields and crude oil prices heighten inflation concerns.

2026-07-30 23:21; UTC

Baxter International Inc shares are lower in after-market trading, reflecting unusual volatility despite strong performance over the past month.

2026-07-29 22:02; UTC

Baxter International Inc. shares are lower in after-market trading, mirroring the broader market's decline amid geopolitical tensions and inflation concerns.

2026-07-28 22:41; UTC

Baxter International Inc shares rose in after-market trading, continuing a trend of higher daily closes and remaining above the 20-day moving average.

2026-07-27 19:21; UTC

News

Baxter International shares are higher as TD Cowen raises the price target to $24.00, reflecting positive sentiment in the Health Care Equipment sector.

2026-07-24 19:02; UTC

Baxter International Inc shares are higher, reflecting market response to a decline in crude oil prices that eased inflationary pressures.

2026-07-22 19:56; UTC

News

Baxter International faces scrutiny over weak growth and declining earnings, contributing to lower shares amid broader weakness in the Health Care Equipment sector.

2026-07-21 23:01; UTC

Baxter International Inc. shares declined in after-hours trading, reflecting a weak performance despite a slight recovery from earlier session lows.

2026-07-20 23:02; UTC

Baxter International Inc shares are higher in after-market trading, reaching 1.27% above Monday's close and near the upper end of their one-month range.

Akcijų palyginimas

Kainos pokytis

Baxter International Inc Prognozė

Kainos tikslas

By TipRanks

-3.11% į apačią

12 mėnesių prognozė

Vidutinis 25.9 USD  -3.11%

Aukščiausias 29 USD

Žemiausias 21 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Baxter International Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

10 ratings

1

Pirkti

9

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

104 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
help-icon Live chat